Cargando…

Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification

TMPRSS2 (Exon 1)-ERG (Exon 4) is the most frequent gene fusion event in prostate cancer (PC), and is highly PC-specific unlike the current serum prostate specific antigen (PSA) biomarker. However, TMPRSS2-ERG levels are currently measured with quantitative reverse-transcription PCR (RT-qPCR) which i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Kevin M., Wee, Eugene J.H., Trau, Matt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924509/ https://www.ncbi.nlm.nih.gov/pubmed/27375789 http://dx.doi.org/10.7150/thno.15250

Ejemplares similares

A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2:ERG gene fusion RNA
por: Koo, Kevin M., et al.
Publicado: (2016)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection
por: Singpanomchai, Nuntita, et al.
Publicado: (2021)

TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
por: Deplus, Rachel, et al.
Publicado: (2016)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Multiplex Detection of Nucleic Acids Using Recombinase Polymerase Amplification and a Molecular Colorimetric 7-Segment Display
por: Li, Jia, et al.
Publicado: (2019)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
por: Giunchi, Francesca, et al.
Publicado: (2020)

PrimedRPA: primer design for recombinase polymerase amplification assays
por: Higgins, Matthew, et al.
Publicado: (2019)

Multiple ligation–Assisted recombinase polymerase amplification for highly sensitive and selective colorimetric detection of SARS-CoV-2
por: Asa, Tasnima Alam, et al.
Publicado: (2023)

P423 Recombinase polymerase amplification for Mucormycosis
por: Hallur, Vinaykumar, et al.
Publicado: (2022)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
por: Li, Chengxun, et al.
Publicado: (2023)

Colorimetric detection of both total genomic and loci-specific DNA methylation from limited DNA inputs
por: Wee, Eugene J. H., et al.
Publicado: (2015)

Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression
por: Yin, Lihong, et al.
Publicado: (2011)

Rapid Detection of Mycobacterium tuberculosis by Recombinase Polymerase Amplification
por: Boyle, David S., et al.
Publicado: (2014)

Recombinase polymerase amplification: Basics, applications and recent advances
por: Lobato, Ivan Magriñá, et al.
Publicado: (2018)

Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
por: Stringer, Oliver W., et al.
Publicado: (2022)

Comprehensive evaluation of molecular enhancers of the isothermal exponential amplification reaction
por: Mok, Ellie, et al.
Publicado: (2016)

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
por: Esgueva, Raquel, et al.
Publicado: (2010)

5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
por: Zammarchi, Francesca, et al.
Publicado: (2013)

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
por: Pascal, Laura E, et al.
Publicado: (2016)

Development of a recombinase polymerase amplification assay for rapid detection of Haemophilus parasuis in tissue samples
por: Han, Qiaoyi, et al.
Publicado: (2020)

Direct and Rapid Detection of Mycoplasma bovis in Bovine Milk Samples by Recombinase Polymerase Amplification Assays
por: Li, Ruiwen, et al.
Publicado: (2021)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2018)

TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa
por: Blackburn, James, et al.
Publicado: (2019)

Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection
por: Abd El Wahed, Ahmed, et al.
Publicado: (2015)

Recombinase polymerase amplification assay for rapid detection of Monkeypox virus
por: Davi, Saskia Dede, et al.
Publicado: (2019)

Recombinase Polymerase Amplification-Based Biosensors for Rapid Zoonoses Screening
por: Feng, Xinrui, et al.
Publicado: (2023)

Applying a Linear Amplification Strategy to Recombinase Polymerase Amplification for Uniform DNA Library Amplification
por: Lee, Jeewon, et al.
Publicado: (2019)

Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer
por: Xu, Zhenyu, et al.
Publicado: (2018)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
por: Semaan, Louie, et al.
Publicado: (2019)

Development of a rapid recombinase polymerase amplification assay for the detection of Streptococcus pneumoniae in whole blood
por: Clancy, Eoin, et al.
Publicado: (2015)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
por: Barwick, B G, et al.
Publicado: (2010)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status
por: Dudka, Ilona, et al.
Publicado: (2020)

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer
por: Yun, Jae Won, et al.
Publicado: (2021)

Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism
por: Bhanushali, Aparna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5uhi2pq232b6lasj550sgobnvq